Microsatellite Instability (MSI) Calculator
Determine a tumor’s MSI status (MSI-H, MSI-L, or MSS) based on standard molecular testing criteria.
Calculated MSI Status:
Instability Visualization
| Parameter | Value | Description |
|---|---|---|
| Total Markers | 5 | The complete number of loci in the panel. |
| Unstable Markers | 0 | Markers identified as having allelic shifts. |
| Instability Score | 0.00% | The percentage of unstable markers. |
| Final Status | – | The clinical classification of the tumor’s instability. |
What is a calculator msi?
A calculator msi, in the context of clinical oncology and genetics, is a tool designed to determine the Microsatellite Instability (MSI) status of a tumor. Microsatellites are short, repeated sequences of DNA. Instability in these sequences occurs when the machinery that repairs DNA errors, known as the Mismatch Repair (MMR) system, is deficient. This deficiency leads to an accumulation of mutations, particularly insertions or deletions in the microsatellite regions. Comparing the length of these microsatellites in tumor tissue versus normal tissue allows for classification into one of three categories: MSI-High (MSI-H), MSI-Low (MSI-L), or Microsatellite Stable (MSS). This calculator msi simplifies that classification process based on laboratory findings.
This status is a critical biomarker, especially in colorectal, gastric, and endometrial cancers. A tumor’s MSI status provides profound insights into its prognosis and, most importantly, its likely response to certain treatments, particularly immune checkpoint inhibitors. For more on this, see our guide on {related_keywords}.
The calculator msi Formula and Explanation
There isn’t a single mathematical formula, but rather a set of classification rules established by consensus panels, most notably the National Cancer Institute (NCI)/Bethesda guidelines. The logic our calculator msi uses is based on these widely accepted clinical standards.
1. For Standard 5-Marker Panels:
This is the most common approach and is the default for our calculator.
- MSI-High (MSI-H): ≥2 of the 5 markers are unstable (≥40%).
- MSI-Low (MSI-L): 1 of the 5 markers is unstable (20%).
- Microsatellite Stable (MSS): 0 of the 5 markers are unstable (0%).
2. For Custom or Larger Panels:
When panels with more markers are used, a percentage-based threshold is applied.
- MSI-High (MSI-H): ≥30% of markers show instability.
- MSI-Low (MSI-L): >0% but <30% of markers show instability.
- Microsatellite Stable (MSS): 0% of markers show instability.
| Variable | Meaning | Unit | Typical Range |
|---|---|---|---|
| Total Markers | The total number of microsatellite loci analyzed in the panel. | Count (unitless) | 5 to 100+ |
| Unstable Markers | The count of loci that show a size variation compared to normal tissue. | Count (unitless) | 0 to Total Markers |
| MSI Status | The final clinical classification. | Category (MSS, MSI-L, MSI-H) | N/A |
Practical Examples
Example 1: Classic MSI-High Case
A pathologist analyzes a colon tumor sample using the standard 5-marker Bethesda panel.
- Inputs: Total Markers = 5, Unstable Markers = 3
- Calculation: Since 3 out of 5 markers are unstable (60%), which is ≥2, the status is determined to be MSI-High.
- Results: The patient’s tumor is MSI-H. This indicates a potential for a strong response to immunotherapy drugs. Learn more about {related_keywords}.
Example 2: Microsatellite Stable Case
A lab performs Next-Generation Sequencing (NGS) on an endometrial tumor, analyzing a large panel of 80 markers.
- Inputs: Total Markers = 80, Unstable Markers = 0
- Calculation: With 0 unstable markers, the instability percentage is 0%.
- Results: The tumor is classified as MSS (Microsatellite Stable). This suggests that the tumor’s growth is not driven by MMR deficiency.
How to Use This calculator msi
Using this calculator msi is straightforward and designed to reflect the workflow of interpreting lab results.
- Enter Total Markers: Input the total number of microsatellite loci that were part of the test panel your lab used. The default is 5 for the standard NCI panel.
- Enter Unstable Markers: Input the number of those markers that were reported as unstable. This value cannot be greater than the total number of markers.
- Review the Results: The calculator will instantly display the primary result (MSI-H, MSI-L, or MSS), the instability percentage, and a visual chart. The interpretation will also be provided. This is crucial for understanding the {related_keywords} of the diagnosis.
- Copy or Reset: Use the ‘Reset’ button to clear the inputs to their default state. Use the ‘Copy Results’ button to save a summary to your clipboard for documentation.
Key Factors That Affect calculator msi Results
- Tumor Type: The incidence of MSI varies significantly across cancer types. It is most common in endometrial, colorectal, and gastric cancers.
- Germline vs. Somatic Origin: MSI can be caused by an inherited mutation in an MMR gene (Lynch syndrome) or by somatic (non-inherited) changes, most commonly methylation of the MLH1 gene promoter.
- Panel Selection: The specific set of markers used for testing can influence results. While the 5-marker panel is standard, larger NGS panels may offer greater sensitivity.
- Testing Methodology: The two primary methods are PCR-based analysis and immunohistochemistry (IHC) which stains for the absence of MMR proteins. While they are highly concordant, discrepancies can occur. Our calculator msi is based on PCR/NGS results. See more on {related_keywords}.
- Tumor Purity: A low percentage of tumor cells in the tissue sample can potentially lead to a false-negative (MSS) result because the signal from normal cells overwhelms the unstable signal from tumor cells.
- Interpretation Criteria: While the Bethesda guidelines are standard, some labs may use slightly different thresholds, especially for large, custom panels.
Frequently Asked Questions (FAQ)
An MSI-H status is generally good news. These tumors are highly responsive to immunotherapy (checkpoint inhibitors) because their high mutation load makes them more visible to the immune system. They can sometimes have a better prognosis regardless of treatment.
Not necessarily. While nearly all tumors from patients with Lynch syndrome are MSI-H, many MSI-H tumors arise sporadically (not inherited), usually due to methylation of the MLH1 gene. An MSI-H result should trigger further testing to rule Lynch syndrome in or out.
The clinical significance of MSI-L is still debated and an area of active research. For most current clinical purposes, MSI-L tumors are treated similarly to MSS tumors and are not considered candidates for immunotherapy based on this status alone.
Yes. You can adjust the “Total Markers in Panel” field. If the number is not 5, the calculator automatically switches to the percentage-based criteria (e.g., ≥30% for MSI-H).
The inputs are simple counts of genetic markers, which are discrete, unitless quantities. The result is a classification category, not a measured value.
MSI-H is a major cause of high TMB. The failure of the DNA repair system leads to a massive accumulation of mutations, hence a high TMB. They are related but distinct biomarkers. A high TMB is another indicator for immunotherapy response. Exploring {related_keywords} can provide more context.
A tumor’s fundamental MSI status (being driven by MMR deficiency) does not typically change. It’s a foundational characteristic of the tumor’s biology.
No. This calculator msi is an educational and informational tool for interpreting pre-existing lab results. All medical diagnoses and treatment decisions must be made by qualified healthcare professionals.
Related Tools and Internal Resources
For further reading and related calculations, please explore the following resources:
- {related_keywords}: Understand the broader context of genetic biomarkers in cancer.
- {related_keywords}: Dive deeper into the mechanisms of DNA repair and its clinical implications.
- {related_keywords}: Learn about the primary cancer associated with MSI.
- {related_keywords}: A calculator for another important clinical score.
- {related_keywords}: Explore risk factors and screening guidelines.
- {related_keywords}: Information on the leading hereditary syndrome linked to MSI.